Juan Carlos López is Managing Director, Research Grants, at the RTW Charitable Foundation. A native of Oaxaca, Mexico, Juan Carlos obtained his PhD from Columbia University (New York) in the laboratory of Nobel Laureate Eric Kandel and carried out postdoctoral research at the Instituto Cajal (Madrid).
In 2000, Juan Carlos moved to London to launch the journal Nature Reviews Neuroscience, subsequently becoming its Chief Editor. Four years later, he returned to New York as Chief Editor of the prestigious journal Nature Medicine. In 2014, Juan Carlos joined Hoffmann-La Roche as Head of Academic Relations and Collaborations, leading a team in charge of fostering scientific interactions between the company and academic institutions worldwide. After leaving Roche, Juan Carlos founded Haystack Science, a consulting firm specialized in editorial services and science commercialization. In 2020, Juan Carlos returned to the pharmaceutical industry as Director of Academic Research Collaborations at Bristol Myers Squibb. Throughout his career, Juan Carlos has served on the Boards of multiple organizations in the non-profit and biotechnology sectors, most recently on the Board of Directors of Keystone Symposia.
For decades, chemistry and biotechnology have been the engines driving the development of new therapies. But now it’s the turn of genetics and genomics to take center stage, and nowhere is this more evident than in the case of rare diseases. It is therefore a great privilege to participate in this revolution in therapeutics as a member of the RTW Charitable Foundation team. We are committed to accelerating the development of new treatments for ultrarare diseases, improving the lives of patients and their families.